Dr. Krishna Pachipala, MD
book an appointment
Dr. Krishna Pachipala, MD
Medical Oncology
Dr. Krishna Pachipala, MD is a medical oncologist in Houston, TX and has over 30 years of experience in the medical field. He graduated from Kurnool Medical College in 1991. He is affiliated with medical facilities such as Houston Methodist the Woodlands Hospital and HCA Houston Healthcare Kingwood. He is accepting new patients and telehealth appointments.
Locations
Millennium Oncology
Krisna Pachipala MD
At a Glance
- Areas of Expertise • Dr. Pachipala specializes in the areas of Hematology, Internal Medicine, Medical Oncology & Oncology. See board certifications
- Explains Conditions Well • Patients said this doctor explains conditions well. See reviews
- Offers Telehealth • This doctor offers telehealth appointments. Call the office to schedule an appointment.
- Practices at Top Hospital • America's 250 Best Hospitals Award™ See hospitals
More Oncology Specialists at HCA Houston Healthcare Kingwood
Experience Check
Search for experience in a specific area
Dr. Pachipala's Reviews
Likelihood to recommend Dr. Pachipala
4.5
| 5 Star | 88% | 88% |
| 4 Star | 0% | 0% |
| 3 Star | 0% | 0% |
| 2 Star | 0% | 0% |
| 1 Star | 12% | 12% |
Leave a review
How was your experience with Dr. Pachipala?Is this your profile?
Respond to reviews, add information, and reach more patients. Claiming is free and only takes a minute.
Claim your profileOverall Patient Satisfaction
Likelihood of recommending Dr. Pachipala to family and friends is 4.52 out of 5
Insurance Check
Search for your insurance carrier and choose your plan type
About Me
care philosophy
Evidence based care with compassion. Areas of expertise: Breast cancer, Lung cancer, Colon cancer, Lymphoma, Myeloma.biography
Dr. Pachipala joined Woodlands Cancer Institute in 2024. He places great emphasis on patient centered care, education, communication and evidence based medicine.Medical Oncology
*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.
University Of Texas Health Science Cente
Fellowship HospitalGeisinger Medical Center
Residency HospitalGeisinger Medical Center
Internship HospitalKurnool Medical College
Medical School, 1991
Healthgrades receives board action history for physicians and physician assistants. The information displayed here is sourced from independent information providers, such as state board websites, and may not be the most up-to-date information. Healthgrades makes no representations with respect to the accuracy of any information provided here and assumes no responsibility or liability for such information.
Learn more about medical license public record checkEnglish
Hindi
Punjabi
Telugu
Parathyroid carcinoma: Two cases diagnosed preoperatively, April 2004
Gestational diabetes mellitus (GDM): Comparison of diagnostic criteria, and results of a screening program, 1999
Thrombin plug: A novel treatment for persistent biliary leak, Sep 2001
Angiotropic large cell lymphoma presenting as fever of unknown origin (FUO), Nov 2002
Case of scurvy presenting as pseudo-vasculitis in a patient with schizophrenia, April 2003
Small-Cell Cancers, and an Unusual Reaction to Chemotherapy: case 4. Fluorouracil-related small bowel vasculitis., June 2003
Emergency medical admissions in patients with diabetes: Increased rate of admission and length of stay, 1999
Sarcoidosis associated hypercalcemia in a patient with chronic renal failure., April 2002
Clinical Study Protocol G1T28-03 Phase 1b/2a Safety and Pharmacokinetic Study of G1T28 in Patients with Previously Treated Extensive-Stage Small Cell Lung Cancer (SCLC) Receiving Topotecan Chemotherapy, 04/2007
2012-PT032: A Phase III Double- blinded, Placebo Controlled Study of Xilonix for Improving Survival in Metastatic Colorectal Cancer, 03/2014
Oncology Clinical Protocol CLEE011G2301 (EarLEE-1) A phase III, multicenter, randomized, double-blind, placebo-controlled study to evaluate efficacy and safety of Ribociclib with endocrine therapy as an adjuvant treatment in patients with hormone receptor-positive, HER2-negative, high risk early bre, 12/2007
CLEE011F2301: A randomized double-blind, placebo-controlled study of ribociclib in combination with fulvestrant for the treatment of postmenopausal women with hormone receptor positive, HER2-negative, advanced breast cancer who have received no or only one line of prior endocrine treatment, 09/2015
Member of Geisinger’s Medical Jeopardy team that won the championship between hospitals in Central Pennsylvania in 2002 and 2nd place at state level
Clinical Protocol CA209-816 Randomized, Open-Label, Phase 3 Trial of Nivolumab and Ipilimumab versus Platinum-Doublet Chemotherapy in Early Stage NSCLC (CheckMate 816: CHECKpoint pathway and nivoluMAb clinical Trial Evaluation 816), 06/2007
Publication of research in peer reviewed journals and numerous scientific presentations in national and international meetings
Passed exams and obtained Membership of Royal College of Physicians of London, UK (MRCP-UK) within 6 months (usual time 2 years)
AMERICA'S TOP ONCOLOGIST 2012: awarded by consumerr's research council of America, 2012
Affiliated Hospitals
- Recipient of 49
hospital awardsAmerica’s 50 Best Hospitals for Surgical Excellence Award™ (2025, 2024, 2023)
Top in the nation for providing excellence in patient safety by preventing infections, medical errors, and other preventable complications
View all awardsAmerica's 250 Best Hospitals Award™ (2025, 2024)
Top in the nation for providing excellence in patient safety by preventing infections, medical errors, and other preventable complications
View all patient feedbackHow patients felt about the care they received at this hospital.
77%Patients said they were given information about recovering at home7% lower than the national average
71%Patients said their room and bathroom were always kept clean4% higher than the national average
- Recipient of 24
hospital awardsAmerica's 250 Best Hospitals Award™ (2025, 2024)
Top in the nation for providing excellence in patient safety by preventing infections, medical errors, and other preventable complications
View all awardsPatient Safety Excellence Award™ (2025, 2024, 2023)
Top in the nation for providing excellence in patient safety by preventing infections, medical errors, and other preventable complications
View all patient feedbackHow patients felt about the care they received at this hospital.
86%Patients said they were given information about recovering at home2% higher than the national average
82%Patients would recommend the hospital to friends and family17% higher than the national average
- Recipient of 5
hospital awards
Your trust is our top concern. Learn more.
We monitor all reviews to ensure they comply with our guidelines and don’t include personal information, profanity, libel, defamation, harassment, obscenity or fraud.
All reviews are confirmed and audited before publication, and community members have the ability to flag inappropriate content for further review by our team.
Doctors can not pay for good reviews, nor can they pay to have negative reviews removed.
Any reviews that are deemed fraudulent or violate our guidelines will be removed immediately.